Haemonetics Corp.
HAE
Market Cap$3.25B
Close$
$169.08
140% upside
Current Fair Value
140% upsideUndervalued by 140% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.25 Billion |
|---|---|
| Enterprise Value | $4.17 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $3.31 |
| Beta | 0.32 |
| Outstanding Shares | 49,193,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 19.86 |
|---|---|
| PEG | 10.76 |
| Price to Sales | 2.61 |
| Price to Book Ratio | 3.71 |
| Enterprise Value to Revenue | 3.06 |
| Enterprise Value to EBIT | 18.42 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 1.29 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Haemonetics Corp.
CEO: Christopher Simon